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Abstract
Objectives:  This  review  aimed  to  organize  and  consolidate  the  latest  knowledge  about  muta-
tions and  genetic  polymorphisms  related  to  hereditary  thrombophilia  and  their  potential
association  with  pediatric  stroke  and  cerebral  palsy  (CP).
Sources:  Scientiﬁc  articles  published  from  1993  to  2013,  written  in  Portuguese,  English,  French,
and  Spanish,  were  selected  and  reviewed.  The  publications  were  searched  in  electronic
databases,  and  also  in  the  collections  of  local  libraries.  The  terms  ‘‘hereditary  thrombophilia’’,
‘‘polymorphisms’’,  ‘‘mutation’’,  ‘‘pediatric  strokes’’,  and  ‘‘cerebral  palsy’’  were  used  for  the
research.
Summary  of  the  ﬁndings:  The  search  in  databases  and  in  the  bibliographic  references  retrieved
75 articles  for  inclusion  in  this  review.  Studies  that  investigated  hereditary  thrombophilias  and
their  associations  to  CP  and  arterial  and  venous  pediatric  stroke  presented  contradictory  results.
The  meta-analysis  and  case-control  studies  that  showed  positive  results  for  this  association
described  only  slightly  increased  relative  risks  and  sometimes  had  questionable  conclusions.  The
association  of  two  or  more  hereditary  thrombophilias,  or  the  association  between  thrombophilia
and  other  speciﬁc  clinical  risk  factors,  suggest  a  higher  risk  of  CP  and  pediatric  stroke  than
isolated  hereditary  thrombophilia.
Conclusions: Larger,  multicenter  studies  should  be  developed  in  order  to  elucidate  the  role  of
mutations  leading  to  hereditary  thrombophilia  and  the  development  of  CP  and  pediatric  stroke.
The  complex  and  multifactorial  etiology  of  CP  and  stroke  makes  this  an  arduous  and  difﬁcult
task;  however,  the  beneﬁts  generated  by  these  studies  are  immeasurable.
© 2014  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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Revisão  sistemática:  tromboﬁlias  hereditárias  associadas  aos  acidentes  vasculares
cerebrais  pediátricos  e  a  paralisia  cerebral
Resumo
Objetivo:  Sistematizar  e  integrar  os  últimos  conhecimentos  sobre  mutac¸ões  e  polimorﬁsmos
genéticos relacionados  às  tromboﬁlias  hereditárias  e  suas  potenciais  associac¸ões  com  acidentes
vasculares  cerebrais  pediátricos  (AVC)  e  paralisia  cerebral  (PC).
Fontes de  Dados:  Artigos  cientíﬁcos  publicados  de  1993  a  2013,  escritos  em  português,  inglês,
francês e  espanhol  foram  selecionados  e  revisados.  As  publicac¸ões  foram  pesquisadas  nas  bases
de  dados  eletrônicas,  como  também  nos  acervos  das  bibliotecas  locais.  Os  termos  mutac¸ão,
polimorﬁsmos,  tromboﬁlias  hereditárias,  acidentes  vasculares  cerebrais  pediátricos  e  paralisia
cerebral  foram  utilizados  para  a  pesquisa.
Síntese  dos  Dados:  A  pesquisa  nas  bases  de  dados  e  nas  referências  bibliográﬁcas  identiﬁcou
75 artigos  para  inclusão  nesta  revisão.  Os  estudos  que  investigaram  as  tromboﬁlias  hereditárias
e  suas  associac¸ões  à  PC  e  aos  AVC  pediátricos  arteriais  e  venosos  apresentaram  resultados  con-
traditórios.  As  metanálises  e  os  estudos  caso-controle  que  demonstraram  resultados  positivos
para  esta  associac¸ão,  descreveram  riscos  relativos  discretamente  aumentados  e,  algumas  vezes,
questionáveis.  A  associac¸ão  de  duas  ou  mais  tromboﬁlias  hereditárias,  ou  a  junc¸ão  de  tromboﬁl-
ias  especíﬁcas  com  demais  fatores  de  riscos  clínicos,  sugerem  maior  risco  no  aparecimento  da
PC  e  do  AVC  pediátrico  do  que  as  tromboﬁlias  hereditárias  isoladas.
Conclusões:  Estudos  multicêntricos  de  grande  porte  devem  ser  conduzidos  para  elucidar  o  papel
real das  mutac¸ões  que  levam  às  tromboﬁlias  hereditárias  e  ao  aparecimento  da  PC  e  AVC
pediátricos. A  etiologia  multifatorial  e  complexa  da  PC  e  dos  AVC  torna  esta  tarefa  árdua  e
difícil,  porém,  os  benefícios  gerados  por  estes  estudos  são  incalculáveis.
© 2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Mutations  in  genes  associated  with  the  coagulation  cascade
trigger hypercoagulable  states  (hereditary  thrombophilia)
that, in  theory,  increase  the  risk  of  stroke  and  cerebral  palsy
(CP). In  children,  the  incidence  of  different  types  of  stroke
varies from  0.67  to  23  per  100,000  live  births  and  the  evo-
lution of  these  lesions  to  CP  is  quite  signiﬁcant  (Table  1).1--7
CP  is  the  most  common  motor  manifestation  of  childhood
and its  prevalence  in  Brazil  is  estimated  at  about  30,000  to
40,000 new  cases  per  year.8,9
The  main  mutations  associated  with  prothrombotic  states
are described  in  factor  V  Leiden,  prothrombin  G20210A  in
methylenetetrahydrofolate reductase  (MTHFR;  C677  T  and
A1298 C),  in  protein  C,  in  protein  S,  in  antithrombin  and
lipoprotein-A.10 The  presumed  physiopathology  for  these
mutations is  described  in  Table  2.10--12
The  aim  of  this  study  was  to  systematically  review  and
consolidate the  studies  that  evaluated  the  mutations  and
polymorphisms in  genes  associated  with  hereditary  throm-
bophilias and  their  possible  associations  with  pediatric
stroke and  cerebral  palsy.
MethodsThe  study  consisted  of  a  systematic  review  of  the  main
publications that  described  mutations  related  to  hereditary
thrombophilias and  their  potential  associations  with  pedi-
atric stroke  and  cerebral  palsy.
(
d
l
oPublication  dates  were  1993-2013  and  languages
ccepted for  reading  were  Portuguese,  English,  French,
nd Spanish.  Research  on  the  subject  was  conducted  in
lectronic databases  (Medline,  PubMed,  SciELO,  OVID,  Web
f Science,  Elsevier  ScienceDirect,  and  CAPES  Journals)
nd in  the  collections  of  the  libraries  of  the  Pontifícia
niversidade Católica  de  Goiás  and  Universidade  Federal
e Goiás.  The  terms  hereditary  thrombophilia,  mutations,
olymorphisms, pediatric  stroke,  and  cerebral  palsy  were
sed for  the  research.  The  methodology  used  was  described
y Green.13
Publications  such  as  meta-analyses,  case-control  studies,
ase series,  and  descriptions  of  clinical  cases  were  included.
he research  in  the  databases  identiﬁed  1,731  potential  arti-
les for  inclusion  in  the  review.  After  reading  the  abstracts
7 articles  were  selected  for  full  reading,  of  which  seven
ere excluded  for  not  meeting  the  criteria  for  the  diagnosis
f CP  or  due  to  duplicity.  The  search  of  the  references  from
he studies  that  were  read  in  full  resulted  in  the  inclusion
f 15  new  articles.
Pediatric stroke  can  be  divided  into  arterial,  ischemic
nd hemorrhagic,  and  venous  stroke.  These  are  also  classi-
ed into  perinatal,  when  they  occur  during  pregnancy  up  to
8 days  of  life,  and  childhood  stroke.1,2,14 According  to  the
006 International  Workshop  on  Deﬁnition  and  Classiﬁcation
f Cerebral  Palsy  of  Maryland,  the  term  cerebral  palsy
CP) describes  a  group  of  permanent  disorders  in  the
evelopment of  movement  and  posture,  causing  activity
imitation, attributed  to  nonprogressive  disorders  that
ccurred in  the  developing  fetal  or  infant  brain.  The
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Table  1  Association  between  stroke  and  CP.
Type  of  stroke  Incidence  Evolution  to  cerebral  palsy
Perinatal  arterial  ischemic
Childhood arterial  ischemic  stroke
17  to  23  per  100,000  live  births1,2
17-fold  less  than  perinatal  AI1,2
68%  to  78%  (87.  6%  hemiplegic  and
12.4% tetraplegic)5,6
Central  venous  thrombosis  0.67  for  every  100,000  children3 67%7
Perinatal  hemorrhagic
Childhood  hemorrhagic
2-3  per  100,000  children4 Sequelae  in  42%  of  cases,  among
Table  2  Presumed  physiopathology  of  mutations  in  genes
related  to  coagulation  cascade  clotting  factors  in  prothrom-
botic states.
Factors  Physiopathology
Factor  V  Leiden  The  point  mutation  in  Factor  V  makes  it
resistant  to  the  proteolytic  action  of
protein  C,  leading  to  increased
generation of  thrombin.
PT  G20210A  The  mutation  results  in  increased
plasma levels  of  prothrombin,  which
leads  to  a  hypercoagulable  state.
MTHFR C677  T  The  mutation  reduces  the  enzyme
activity  and  leads  to  increased  levels  of
homocysteine,  which  has  a
prothrombotic  effect.
ATIII  deﬁciency  Multifunctional  serpin  that  inhibits
activated  clotting  enzymes  (IIa,  IXa,  Xa,
XIa)  in  the  coagulation  cascade.
PROC  deﬁciency Vitamin  K-dependent  protein  with
anticoagulant  action.
PROS  deﬁciency Vitamin  K-dependent  PROC  cofactor.
Elevated
lipoprotein-A
Due to  its  homology  to  plasminogen,  this
reduces  plasmin  generation  by
competing  with  plasminogen  binding  to
ﬁbrin.
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aSource: Zadro & Herak, 201210. Adapted.
otor  disorders  of  cerebral  palsy  are  often  accompanied
y sensory,  perception,  cognition,  communication,  and
ehavior disorders,  as  well  as  epilepsy  and  secondary
usculoskeletal  problems.15--17
esults
he  literature  review  selected  articles  that  investigated
otential associations  between  hereditary  thrombophilia
nd CP  or  between  hereditary  thrombophilia  and  pediatric
troke, including  arterial  ischemic  (AI)  stroke,  hemorrhagic
troke, and  cerebral  venous  thrombosis  (CVT).  The  research
esulted in  different  types  of  studies;  however,  the  case-
ontrol studies  and  meta-analyses  were  favored,  as  they
ave the  greatest  impact  on  the  area  knowledge,  while  the
linical case  studies  and  case  series  were  only  brieﬂy  men-
ioned.
The literature  review  of  studies  investigating  the  associ-
tion between  hereditary  thrombophilia  and  CP  resulted  in
ve case  reports,18--23 four  series  studies,14,24--26 and  seven
r
a
i
ethem  CP4
ase-control  studies.  The  results  of  the  case-control  stud-
es are  summarized  in  Table  3.  Of  the  studies  that  aimed  to
escribe an  association  between  hereditary  thrombophilia
nd CP,  most  failed  to  determine  an  association.11,27--30
Only  two  studies  have  been  able  to  establish  some
egree of  association,  especially  the  study  by  Dekker,31
hich  showed  a higher  risk  of  CP  in  preterm  infants  with
he MTHFR  C677  T  mutation  in  homozygous  state,  and  in
atients who  accumulate  both  MTHFR  C677  T  polymorphisms
n homozygous  state  and  PT  G20210A  polymorphisms,  in  het-
rozygous  state.  The  study  by  Nelson  et  al.32 was  the  only
ne that  showed  a  signiﬁcant  association  between  an  iso-
ated hereditary  thrombophilia  (fVL)  and  CP,  without  sample
tratiﬁcation.
The literature  review  on  the  association  between  hered-
tary thrombophilias  and  perinatal  AI  stroke  resulted  in  one
ase report,33 eight  case-control  studies,  and  two  meta-
nalyses. The  studies  on  the  association  between  hereditary
hrombophilias and  childhood  AI  stroke,  obtained  from
he databases,  totaled  16  case-control  studies  and  two
eta-analyses. The  case-control  studies  published  during
he study  period  showed  discordant  results  on  the  higher
requency of  hereditary  thrombophilia  in  patients  with  peri-
atal AI  stroke  (Table  4).34--42
The  meta-analyses  assessed  together  the  relative  risk
f hereditary  thrombophilia  for  patients  with  perinatal  and
hildhood AI  stroke.  Renaud  et  al.43 found  a  greater  preva-
ence of  FVL  mutation  and  PT  G20210  mutation  in  these
atients, when  compared  to  controls.
Kenet  et  al.12 reported  higher  frequencies  for  FVL  (OR:
.70; 95%  CI:  2.82  to  4.85)  for  the  PT  G20210A  mutation
OR: 2.60;95%  CI:  1.66  to  4.08)  for  the  MTHFR  C677  T  muta-
ion in  homozygous  state  (OR:  1.58;  95%  CI:  1.20  to  2.08),
or PROC  deﬁciency  (OR:  11.0;  95%  CI:  5.13  -23.59)  and  for
levated lipoprotein  A  (OR:  6.53;  95%  CI:  4.46  to  9.55)  in
he group  of  patients  when  compared  to  controls.  The  asso-
iation of  two  or  more  hereditary  thrombophilias  was  also
8.75-fold higher  (95%  CI:  6.49  to  54.14)  in  the  assessed
atients. This  meta-analysis  found  no  increase  in  the  rela-
ive risk  for  antithrombin  deﬁciency  (OR:  3.29;  95%  CI:  0.70
o 15.48)  and  S  protein  deﬁciency  (OR  1.49;  95%  CI:  0.32  to
.92).
Sixteen case-control  studies  investigated  the  associ-
tions between  hereditary  thrombophilia  and  childhood
I stroke.  The  results  of  these  studies  were  divergent
nd are  shown  in  Table  4.44--61 The  literature  survey  also
etrieved two  meta-analyses  that  evaluated  the  probable
ssociations between  mutations  in  genes  linked  to  hered-
tary thrombophilia  and  childhood  stroke.12,62 Haywood
t al.62 evaluated  case-control  studies  published  between
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Table  3  Studies  that  assessed  direct  associations  between  CP  and  hereditary  thrombophilias  (author,  year,  country,  type  of
study  and  analyzed  genes).
References  Country  Study  type  Cases  (n)  Controls  (n)  Analyzed  genes  Results  found
Nelson  et  al.,  199832 United
States
Case-control  31  65  fVL  Signiﬁcant
increase
Gibson  et  al.,  200327 United
States
Case-control  354  708  fVL,  PT20210,
MTHFR  C677  T,  and
A1298G
Non-signiﬁcant
difference
Yehezkely-Schildkraut
et  al.,  200511
Israel  Case-control  61  62  fVL,  PT20210,
MTHFR  C677  T
Non-signiﬁcant
difference
Reid  et  al.,  200628 Canada  Case-control  57  167  fVL  Non-signiﬁcant
difference
Dekker,  200731 Australia  Case-control  443  883  MTHFR  C677  T
PT20210
Increased  risk  in
speciﬁc groups
Wu et  al.,  201129 United
States
Case-control  138  165  fVL,  PT20210,
MTHFR  C677  T
Non-signiﬁcant
difference
Arenas-Sordo  et  al., Mexico  Case-control  94  120  fVL  Non-signiﬁcant
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1989  and  2000  and  demonstrated  a  higher  frequency  of
PROC deﬁciency  (OR:  11.0;  95%  CI:  5.1  to  23.6)  and  the
MTHFR C677  T  mutation  (OR:  1.70;  95%  CI:  1.23  to  2.34)
in patients  with  childhood  AI  stroke.  The  authors  did  not
observe increased  frequencies  for  FVL  (OR:  1.2;  95%  CI:  0.8-
1.9), for  the  PT  G20210A  mutation  (OR:  1.1;  95%  CI:  0.5-
2.3), for  antithrombin  deﬁciency  (OR:  1.0;  95%  CI:  0.3  to
3.7), and  for  PROS  deﬁciency  (OR:  1.1;  95%  CI:  0.3-3.8)  in
cases when  compared  to  controls.
The  literature  review  on  the  association  between  hered-
itary thrombophilias  and  pediatric  CVT  retrieved  one  case
report63 and  one  case  series.64 The  literature  search  also
retrieved six  case-control  studies,38,41,53,65--67 which  showed
conﬂicting results  on  the  inﬂuence  of  hereditary  throm-
bophilia on  CVT  (Table  4).
The  meta-analyses  indicated  that,  in  patients  with  CVT,
there was  a  greater  frequency  for  FVL  mutation  (2.7-3.1
times), PT  G20210A  mutation  (1.9-3.1  times),  protein  C  deﬁ-
ciency (6.3  times),  protein  S  deﬁciency  (5.3  times),  and
ATIII deﬁciency  (18.4  times),  as  well  as  elevated  lipoprotein-
A levels  (7.2  times).  However,  these  ﬁndings  were  not
observed for  the  MTHFR  C677  T  mutation  in  homozygous
state.12,41
Four  case-control  studies60,68--70 and  a  series  study71
that  correlated  hereditary  thrombophilias  with  hemorrhagic
stroke were  selected  for  the  present  review.  All  studies
referred to  germinal  matrix-intraventricular  hemorrhage
(GM-IVH) in  the  neonatal  period.  Condensed  data  from  these
studies are  presented  in  Table  5.  Two  case-control  studies
selected in  this  review  showed  no  increased  relative  risk  for
FVL, PT  G20210A,  and  MTHFR  C677  T  mutations  in  patients
with GM-IVH,  when  compared  to  controls.68,72
Göpel  et  al.72 observed  that  FVL  and  PT  G20210A  muta-
tions conferred  a  negative  relative  risk  for  more  severe
forms of  GM-IVH,  suggesting  a  protective  effect  against
the worsening  of  bleeding  caused  by  these  mutations.  One
possible explanation  is  the  faster  coagulation  due  to  throm-
bophilia.
i
p
b
idifference
Komlósi  et  al.69 demonstrated  a higher  frequency  of  FVL
n premature  patients  with  GM-IVH  when  compared  to  con-
rols; however,  these  results  were  not  conﬁrmed  for  patients
orn at  term.  Ramenghi  et  al.70 observed  a  higher  frequency
or the  combination  of  FVL  and  prothrombin  G20210A  muta-
ion in  patients  with  GM-IVH  when  compared  to  controls.  The
rouping of  different  thrombophilias  hinders  conclusions  on
he physiological  role  of  each  individual  type  and  is  usually
ssessed in  very  small  samples.
iscussion
f  the  studies  that  aimed  to  describe  a  direct  correla-
ion between  hereditary  thrombophilias  and  CP,  most  failed
o establish  this  association,11,27--32 suggesting  a  secondary
ffect of  thrombophilia  on  the  onset  of  CP.
The  results  obtained  for  AI  stroke  are  very  similar  for
he two  pediatric  periods  (perinatal  and  childhood).  Individ-
al analysis  of  genetic  factors  associated  with  thrombophilia
hows a  discrete  role  in  the  onset  of  pediatric  arterial
schemic stroke.  The  combination  of  two  or  more  heredi-
ary thrombophilias  with  other  clinical  risk  factors  appears
o be  more  signiﬁcant  in  clinical  practice  than  the  study  of
solated genetic  factors.12 This  fact  prevents  the  diagnosis
f isolated  mutations  from  determining  clinical  management
onclusively, as  the  risk/beneﬁt  of  anticoagulants  and  other
edications has  yet  to  be  established.73
The  conclusions  obtained  on  the  role  of  hereditary  throm-
ophilias in  the  etiology  of  pediatric  AI  stroke  are  also  valid
or the  onset  of  CVT  in  childhood.  Thrombophilias  result
n a  small  and  questionable  increase  in  the  relative  risk
f CVT.  This  fact,  added  to  the  low  prevalence  of  CVT
n childhood,  hinders  the  use  of  these  results  in  medical
ractice.12 In  this  review,  only  studies  on  hereditary  throm-
ophilia and  perinatal  hemorrhagic  stroke  (GM-IVH)  were
ncluded. The  small  number  of  studies  and,  consequently,
26  Torres  VM,  Saddi  VA
Table  4  Integration  of  results  of  case-control  studies  and  meta-analyses  on  possible  associations  between  hereditary  throm-
bophilias  and  perinatal  AI  stroke,  childhood  AI  stroke  and  childhood  CVT.
Hereditary  thrombophilias  Perinatal  AI  stroke  (No.
of  studies)
Childhood  AI  stroke  (No.
of studies)
Childhood  CVT  (No.  of
studies)
Signiﬁcant
positive
association
Non-
signiﬁcant
association
Signiﬁcant
positive
association
Non-
signiﬁcant
association
Signiﬁcant
positive
association
Non-
signiﬁcant
association
Factor  V  Leiden
Case-control  5  3  7  6  2  4
Meta-analysis 2a 0  1a 1  2  0
Prothrombin G20210A
Case-control  0  8  2  6  1  4
Meta-analysis 2a 0  1  1a 2  0
MTHFR C677  T  HOMO
Case-control  0  6  1  10  0  3
Meta-analysis 1a 0  2a 0  0  0
ATIII deﬁciency
Case-control  0b 3b 0b 3b 1  1
Meta-analysis 0  1a 0  2a 1  0
Protein C  deﬁciency
Case-control  2  1  2  1  1  1
Meta-analysis 1a 0  2a 0  1  0
Protein S  deﬁciency
Case-control  0b 3b 0b 3b 1  1
Meta-analysis 0  1a 0  2a 1  0
LP-a increase  (>0.3  mg/L)
Case-control  1  1  2  1  1  0
Meta-analysis 1a 0  1a 0  0  0
Two or  more  risk  factors
Meta-analysis 1a 0  1a 0  0  1
0 1
a Includes studies with conjoined data for perinatal AI stroke and Childhood AI stroke.
b Rare cases found; statistical analysis was not possible.
Table  5  Studies  that  analyzed  possible  associations  between  hemorrhagic  stroke  and  hereditary  thrombophilias.
References  Country  Type  of  study  No.  of  case
patients
No. of
controls
Assessed
genes
Results  found
Göpel  et  al.,
200172
Germany  Case-control  43  262  fVL,  PT20210,
MTHFR  C677  T
Non-signiﬁcant
difference a
Petäjä  et  al.,
200168
Finland  Case-control  22  29  fVL
PT20210
Non-signiﬁcant
difference
Komlósi et  al.,
200569
Hungary  Case-control  125  128  fVL  Signiﬁcant
increase
Ramenghi
et  al.,  201170
UK  Case-control  22  84  fVL
PT20210b
b
 mos
e risk
o
a
b
p
pa The author observed a probable protector effect against the
(GM-IVH).
b The accumulated frequency of the two mutations increased th
f  assessed  cases,  makes  it  difﬁcult  to  obtain  conclusions
68--72bout this  association.
Some  limitations  inﬂuenced  this  review  about  the  possi-
le associations  between  hereditary  thrombophilia,  cerebral
alsy and  stroke.  The  ﬁrst  is  related  to  the  studied
o
o
o
et severe forms of germinal matrix-intraventricular hemorrhage
 of hemorrhagic stroke by 2.65-fold.
atients  that  had  several  acquired  factors  for  the  onset
f pediatric  stroke,  such  as  sepsis  and  dehydration,  among
thers.3 Additionally,  it  is  known  that  the  measurement
f some  proteins  involved  in  coagulation  can  be  inﬂu-
nced by  several  diseases,  such  as  protein  S,  protein  C  and
edia
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2Systematic  review:  hereditary  thrombophilia  associated  to  p
antithrombin,  which  are  affected  by  liver,  kidney,  and  infec-
tious diseases.74
Another  important  limitation  derives  from  the  fact  that
most studies  have  been  performed  in  populations  of  North
America and  Europe.  As  the  frequency  of  hereditary  throm-
bophilia varies  signiﬁcantly  from  population  to  population,
these studies  should  be  replicated  in  different  geographic
regions.62 Finally,  it  should  be  noted  that  some  studies  have
evaluated stroke  globally,  without  classifying  them  into  arte-
rial or  venous,  or  into  perinatal  or  childhood  stroke.  This  fact
was observed  in  two  of  the  meta-analyses  that  assessed  the
association between  hereditary  thrombophilia  and  AI  stroke
and that  performed  data  analyses  of  the  neonatal  and  child-
hood periods  together,  which  hinders  the  analysis  of  the
obtained conclusions.12,43
Conclusions and future perspectives
Regarding  the  potential  effect  of  the  mutations  in  genes
associated with  hereditary  thrombophilia  and  their  associa-
tion with  pediatric  stroke  and  cerebral  palsy,  the  authors
conclude that  small  increases  in  the  relative  risk  were
described in  the  reviewed  studies,  suggesting  a  secondary
role of  these  mutations  in  the  onset  of  these  manifestations.
The combination  of  more  than  one  mutation  associated  with
clinical risk  factors  suggests  a  more  signiﬁcant  role  in  the
etiology of  pediatric  stroke  and  CP.
Multicenter  studies  evaluating  a  larger  number  of  genes
together are  necessary  to  elucidate  the  actual  role  of  the
mutations associated  with  hereditary  thrombophilias  in  the
etiology of  CP/pediatric  stroke.
The  multifactorial  and  complex  etiology  of  CP  makes  this
a difﬁcult  and  arduous  task,  but  the  beneﬁts  generated  by
these studies  are  invaluable.
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